Gaps and Opportunities in HIV Service Delivery in High Volume HIV Care Centers in Liberia: Lessons From the Field.


Journal

Annals of global health
ISSN: 2214-9996
Titre abrégé: Ann Glob Health
Pays: United States
ID NLM: 101620864

Informations de publication

Date de publication:
2021
Historique:
entrez: 13 12 2021
pubmed: 14 12 2021
medline: 11 1 2022
Statut: epublish

Résumé

Human Immunodeficiency Virus (HIV) infection continues to have a profound humanitarian and public health impact in western and central Africa, a region that risks being left behind in the global response to ending the AIDS epidemic. In Liberia, where the health system is being rebuilt following protracted civil wars and an Ebola virus disease outbreak, the Resilient and Responsive Health System (RRHS) is assisting with quality HIV services delivery through support from PEPFAR and HRSA but gaps remain across the cascade of care from diagnosis to viral load suppression. To highlight gaps in HIV service delivery in Liberia, identify opportunities and offer recommendations for improving the quality of service delivery. A narrative review of relevant literature was conducted following a search of all local and online databases known to the authors. Antiretroviral therapy (ART) has transformed the HIV response in Liberia by averting deaths, improving quality of life, and preventing new HIV infections but critical gaps remain. These include weak HIV prevention and testing strategies; suboptimal ART initiation and retention in care; low viral load testing volumes, commodity supply chain disruptions and a HIV workforce built on non-physician healthcare workers. In the context of the prevailing socioeconomic, heath system and programmatic challenges, these will impact achievement of the UNAIDS targets of 95-95-95 by 2030 and ending the epidemic. Combination prevention approaches are necessary to reach the most at risk populations, while a robust health workforce operating through facilities and communities will be needed to reach people with undiagnosed HIV earlier to provide efficient and effective services to ensure that people know their HIV status, receive and sustain ART to achieve viral suppression to maintain a long and healthy life within the framework of overall health system strengthening, achieving universal health coverage and the sustainable development goal.

Sections du résumé

Background
Human Immunodeficiency Virus (HIV) infection continues to have a profound humanitarian and public health impact in western and central Africa, a region that risks being left behind in the global response to ending the AIDS epidemic. In Liberia, where the health system is being rebuilt following protracted civil wars and an Ebola virus disease outbreak, the Resilient and Responsive Health System (RRHS) is assisting with quality HIV services delivery through support from PEPFAR and HRSA but gaps remain across the cascade of care from diagnosis to viral load suppression.
Objective
To highlight gaps in HIV service delivery in Liberia, identify opportunities and offer recommendations for improving the quality of service delivery.
Methods
A narrative review of relevant literature was conducted following a search of all local and online databases known to the authors.
Findings
Antiretroviral therapy (ART) has transformed the HIV response in Liberia by averting deaths, improving quality of life, and preventing new HIV infections but critical gaps remain. These include weak HIV prevention and testing strategies; suboptimal ART initiation and retention in care; low viral load testing volumes, commodity supply chain disruptions and a HIV workforce built on non-physician healthcare workers. In the context of the prevailing socioeconomic, heath system and programmatic challenges, these will impact achievement of the UNAIDS targets of 95-95-95 by 2030 and ending the epidemic.
Conclusion
Combination prevention approaches are necessary to reach the most at risk populations, while a robust health workforce operating through facilities and communities will be needed to reach people with undiagnosed HIV earlier to provide efficient and effective services to ensure that people know their HIV status, receive and sustain ART to achieve viral suppression to maintain a long and healthy life within the framework of overall health system strengthening, achieving universal health coverage and the sustainable development goal.

Identifiants

pubmed: 34900615
doi: 10.5334/aogh.3246
pmc: PMC8622325
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, P.H.S. Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

115

Subventions

Organisme : PEPFAR
Pays : United States

Informations de copyright

Copyright: © 2021 The Author(s).

Déclaration de conflit d'intérêts

The authors have no competing interests to declare.

Références

PLoS Med. 2018 Feb 20;15(2):e1002508
pubmed: 29462138
Clin Infect Dis. 2009 Aug 1;49(3):454-62
pubmed: 19569972
J Int AIDS Soc. 2017 Jan 12;20(1):21188
pubmed: 28364566
Glob Health Action. 2018;11(1):1522150
pubmed: 30270812
Glob Health Sci Pract. 2020 Oct 2;8(3):566-581
pubmed: 33008864
BMJ Open. 2020 Oct 7;10(10):e039237
pubmed: 33033029
Lancet. 2018 Jul 28;392(10144):312-358
pubmed: 30032975
Cochrane Database Syst Rev. 2019 Jun 17;6:CD012962
pubmed: 31206168
Trop Med Int Health. 2009 Aug;14(8):856-61
pubmed: 19552661
Clin Infect Dis. 2016 Apr 15;62(8):1043-8
pubmed: 26743094
PLoS Med. 2020 Feb 14;17(2):e1003028
pubmed: 32059023
Global Health. 2011 Oct 10;7:37
pubmed: 21985150
Hum Resour Health. 2019 Mar 7;17(1):19
pubmed: 30845978
JAMA. 2018 Mar 20;319(11):1103-1112
pubmed: 29509839
Glob Pediatr Health. 2018 Jan 24;5:2333794X18754452
pubmed: 29399603
Emerg Infect Dis. 2016 Mar;22(3):433-41
pubmed: 26886846
AIDS Educ Prev. 2016 Dec;28(6):472-484
pubmed: 27925491
Reprod Health. 2013 Oct 09;10:54
pubmed: 24107301
J Eval Clin Pract. 2005 Jun;11(3):257-73
pubmed: 15869556
BMC Health Serv Res. 2019 May 20;19(1):317
pubmed: 31109335
PLoS One. 2017 Oct 12;12(10):e0186316
pubmed: 29023510
Curr Opin HIV AIDS. 2012 Jul;7(4):299-304
pubmed: 22627711

Auteurs

Mukhtar A Adeiza (MA)

Yale School of Medicine, John F. Kennedy Medical Center, US.

Ian Wachekwa (I)

John F. Kennedy Medical Center, LR.

Cecilia Nuta (C)

John F. Kennedy Medical Center, LR.

Sean Donato (S)

UNICEF Supply Division, DK.

Freda Koomson (F)

Yale School of Medicine, University of Liberia, Redemption Hospital, US.

Jane Whitney (J)

Yale School of Medicine, US.

Chelsea Plyler (C)

Yale School of Medicine, US.

Lila Kerr (L)

Brigham and Women's Hospital, Partners In Health, US.

Godsway Sackey (G)

Brigham and Women's Hospital, Partners In Health, LR.

Elizabeth Dunbar (E)

Resilient and Responsive Health System, University of Washington, US.

Robin Klar (R)

New York University Rory Meyers College of Nursing, US.

Regan H Marsh (RH)

Brigham and Women's Hospital, Partners In Health, US.

Samretta Caldwell (S)

Liberia National AIDS and STI Control Program, LR.

Julia Toomey (J)

Liberia National AIDS and STI Control Program, LR.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH